Removing Racial Inequalities in Lab Referrals
Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities
Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Artificial intelligence won’t take your job—but what are the real concerns around healthcare AI and its use?
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.